Pneumococcal conjugate vaccine

6 marketed 19 in Phase 3

This page covers all Pneumococcal conjugate vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Streptococcus pneumoniae capsular polysaccharides (20 serotypes), Streptococcus pneumoniae polysaccharide antigens (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F), Streptococcus pneumoniae polysaccharide capsule (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F).

Targets

Streptococcus pneumoniae capsular polysaccharides (20 serotypes) · Streptococcus pneumoniae polysaccharide antigens (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F) · Streptococcus pneumoniae polysaccharide capsule (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F) · Streptococcus pneumoniae serotype 3 capsular polysaccharide · Streptococcus pneumoniae polysaccharide capsule (13 serotypes) · Streptococcus pneumoniae polysaccharide antigens (20 serotypes) · Streptococcus pneumoniae polysaccharide capsules (20 serotypes) · Streptococcus pneumoniae capsular polysaccharides (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F) · Streptococcus pneumoniae polysaccharide capsule (21 serotypes) · Streptococcus pneumoniae capsular polysaccharides (serotype-specific)

Marketed (6)

Phase 3 pipeline (19)